Money

Moderna stock surges as FDA reverses course, agrees to review new flu shot

Yahoo News

Health

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal

CNBC - Annika Kim Constantino

US

Moderna says FDA to review its flu vaccine after reversing course

CBS News